In foot and ankle surgery, a 0.2% bolus concentration of ropivacaine in a continuous popliteal nerve block does not reduce the incidence of rebound pain, a new study has concluded.
The researchers could not recommend the use of the lower concentration of ropivacaine over the more typical 0.5% concentration for patients receiving these blocks, largely because of the potential for more overall pain in the immediate postoperative period.